OXFORD ASYMMETRY INTERNATIONAL
Oxford Asymmetry International operates as an outsourcing arm for pharmaceutical companies.
OXFORD ASYMMETRY INTERNATIONAL
Industry:
Outsourcing Pharmaceutical
Founded:
1992-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
44 12 3586 1561
Similar Organizations
Arexis AB
Arexis AB operates as an integrated pharmaceutical company.
More informations about "Oxford Asymmetry International"
Oxford Asymmetry International - PitchBook
Oct 20, 1994 3i Group, Oxford Spin-out Equity Management, and Oxford University Innovation have invested in Oxford Asymmetry International. When was Oxford Asymmetry International …See details»
Edwin MOSES - Keensight Capital
Prior to Ablynx, Dr. Moses was the CEO of OAI (Oxford Asymmetry International), a clinical research organization acquired by Evotec in 2000 for $475m. During his tenure as CEO of …See details»
Oxford Asymmetry merges with Evotec - The Scotsman
Jul 31, 2000 UK biotech group Oxford Asymmetry International is to tie the knot with German rival Evotec in a merger which values the British company at £316 million.See details»
Evotec acquires Oxford Asymmetry International - 2000-08-01 ...
Aug 1, 2000 Oxford Asymmetry International Oxford Asymmetry International operates as an outsourcing arm for pharmaceutical companies. Acquiring Organization: Evotec Evotec is a …See details»
Oxford Asymmetry International Company Profile - Datanyze
Oxford Asymmetry International Profile and History. Oxford Asymmetry International plc provides sophisticated chemical services to the world-wide pharmaceutical, biotechnology and …See details»
Nextsource | Company Profile | Oxford Asymmetry International
Explore the company profile of Oxford Asymmetry International (oai.co.uk) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
BioPharmaLink profile of Oxford Asymmetry International, United …
Oxford Asymmetry International . Oxford Asymmetry International, the ideal chemical discovery and development partner to the pharmaceutical and agrochemical industries, provides a …See details»
Oxford Asymmetry International - Crunchbase
Oxford Asymmetry International operates as an outsourcing arm for pharmaceutical companies.See details»
Evotec wins US contracts - Oxford Mail
Mar 21, 2001 By Maggie Hartford Drug discovery company Evotec OAI, formerly Oxford Asymmetry, has landed two contracts with US pharmaceutical giant Eli Lilly.See details»
Evotec expands again at Milton Park
Jan 29, 2021 Evotec has had a presence at Milton Park ever since the company’s merger with Oxford Asymmetry International plc in 2000. Oxford Asymmetry International had been based …See details»
Evotec expands again at Milton Park - Advanced Oxford
Evotec has had a presence at Milton Park ever since the company’s merger with Oxford Asymmetry International plc in 2000. Oxford Asymmetry International had been based at …See details»
Evotec expands at Milton Park to become one of its largest …
Sep 9, 2020 Oxford Asymmetry International had been based at Milton Park since 1989 in various guises and started in one of the original ex-MOD depot buildings. Evotec’s latest …See details»
Oxford Asymmetry Grows Despite Struggles In UK
Aug 4, 1999 LONDON - Some UK biotechnology companies are struggling but Oxford Asymmetry International plc, which provides chemical services to many of them, reported …See details»
Company - Immunocore
Having started his career in commercial property, Mr Laing has been an active investor in life science and technology businesses for 25 years. He was previously a founder shareholder …See details»
Oxford Asymmetry International - Tech Stack, Apps, Patents
Organization. Oxford Asymmetry International . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. ... Oxford …See details»
Ian Laing - Founder & Non-Executive Director - Crunchbase
Primary Organization . Adaptimmune . ... He was previously a founder shareholder and non-executive director of Oxford Asymmetry. International Plc (subsequently Evotec) from 1992 to …See details»
Ian Nicholson - Chief Executive Officer @ F2G - Crunchbase
In licensing, mergers and acquisitions, and market development in the UK, Europe and the US. Ian has held a variety of senior commercial positions with Oxford Asymmetry International plc, …See details»